Bullement, Ash http://orcid.org/0000-0001-7091-0972
McMordie, Samuel Thomas http://orcid.org/0000-0003-1384-4184
Hatswell, Anthony James http://orcid.org/0000-0003-1129-326X
Li, Nanxin
Wilson, Koo
Article History
First Online: 6 July 2019
Compliance with Ethical Standards
:
: This research was funded by Swedish Orphan Biovitrum AB (publ) (Sobi).
: A. Bullement, S.T. McMordie, and A.J. Hatswell are employees of Delta Hat, a private consultancy that has received funding from Sobi for the research reported within this manuscript. K. Wilson is an employee of Sobi, a company involved in the development and commercialization of rFVIIIFc (Elocta). At the time this study was conducted, N. Li was an employee of Bioverativ (a Sanofi company), a company also involved in the development and commercialization of rFVIIIFc (Elocta). The views expressed are those of the author(s) and not necessarily those of the author affiliations.